The brightest minds in the CDMO industry.

From early development through to commercial manufacturing.


Change in the total number of shares and votes in Recipharm AB (publ)

Update on operational impact of COVID-19

Celebrating 25 years

Recipharm has had an incredible journey since it was formed in 1995, and is now a leading global player in the CDMO industry. This year we celebrate our successful journey over 25 years. 

Founders Thomas Eldered and Lars Backsell:

"Recipharm has not been a two man-show, as there are a lot of people that have contributed over the years, and we’ve been fortunate enough to recruit and retain excellent people."


Whether you’re a large or small pharmaceutical company, our talented team can develop and transform your promising molecule into a product. We’ve supported many clients over the years, and you can be next.

Torkel Gren - General Manager

“Recipharm takes responsibility for the full phase I programme, from formulation to clinical trial implementation with patients.”


With production facilities across the world covering a range of product types and dosage forms, you can count on our manufacturing expertise to reliably deliver your product on time, every time. Shall we get started?

Ann Flodin - General Manager

"We are focused on managing complexity for our customers, this means providing a full service offering to simplify the supply chain."


Proud to become a top five global CDMO

2019 Annual Report

Contact us

Your CDMO partner

Developing pharmaceuticals can be a tricky business, so let us help.